Bruno Flamion

Improving clinical trial sampling for future research - an international approach: outcomes and next steps from the DIA future use sampling workshop 2011.

Yoshiaki Uyama, Bartha Maria Knoppers, Marianna Bledsoe, 2013, Pharmacogenomics.

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Krishna Prasad, Peter Kasper, Jonathan A Phillips, 2010, Nature Biotechnology.

Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance

Sally Okun, Paul Wicks, I. Ralph Edwards, 2013, Drug Safety.

Health Technology Assessment in Osteoporosis

Jean-Pierre Devogelaer, Steven Boonen, Jean-Yves Reginster, 2013, Calcified Tissue International.

Challenges with advanced therapy medicinal products and how to meet them

Robert Zorec, Balázs Sarkadi, Sophie Lucas, 2010, Nature Reviews Drug Discovery.

Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response

Malcolm Rowland, Alasdair Breckenridge, Bruno Flamion, 2011, Nature Reviews Drug Discovery.

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

Alasdair Breckenridge, Bruno Flamion, Francesco Pignatti, 2008, Nature Reviews Drug Discovery.

PRE-MARKET CLINICAL EVALUATIONS OF INNOVATIVE HIGH-RISK MEDICAL DEVICES IN EUROPE

Mattias Neyt, Silvio Garattini, Mirjana Huić, 2012, International Journal of Technology Assessment in Health Care.